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Abstract
In the current era of malaria eradication, reducing transmission is critical. Assessment of transmissibility requires tools that
can accurately identify the various developmental stages of the malaria parasite, particularly those required for transmission
(sexual stages). Here, we present a method for estimating relative amounts of Plasmodium falciparum asexual and sexual
stages from gene expression measurements. These are modeled using constrained linear regression to characterize stage-
specific expression profiles within mixed-stage populations. The resulting profiles were analyzed functionally by gene set
enrichment analysis (GSEA), confirming differentially active pathways such as increased mitochondrial activity and lipid
metabolism during sexual development. We validated model predictions both from microarrays and from quantitative RT-
PCR (qRT-PCR) measurements, based on the expression of a small set of key transcriptional markers. This sufficient marker
set was identified by backward selection from the whole genome as available from expression arrays, targeting one sentinel
marker per stage. The model as learned can be applied to any new microarray or qRT-PCR transcriptional measurement. We
illustrate its use in vitro in inferring changes in stage distribution following stress and drug treatment and in vivo in
identifying immature and mature sexual stage carriers within patient cohorts. We believe this approach will be a valuable
resource for staging lab and field samples alike and will have wide applicability in epidemiological studies of malaria
transmission.
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Introduction
One of the tenets of the recently released Malaria Eradication
Research Agenda (malERA) is the development of new diagnostics
specifically addressing transmission reduction [1]. Individuals
harboring the Plasmodium falciparum transmissible parasite stage,
or gametocyte, are the primary reservoir for malaria transmission,
and thus proper surveillance of gametocyte carriers is critical to
transmission reduction. Surveillance is difficult, however, because
gametocytes comprise only a small fraction of the total body
parasite load during active infection and are only observed in the
bloodstream in their mature form, while developing stages are
sequestered in tissues [2]. For these reasons, quantifying gameto-
cytes in mixed parasite populations has been an ongoing challenge
ever since they were first identified more than a century ago.
Gametocytes do execute substantially different transcription-
al programs from asexual parasite stages, however, as has been
well-studied in vitro [3]. Like the sequential dynamics of the
asexual Plasmodium life cycle [4,5], gametocytes develop in a
staged progression from immature (young and intermediate
stages) to mature transmission-competent cells in preparation
for meiosis and further development in the mosquito vector.
The switch between asexual replication and sexual develop-
ment does not occur ubiquitously in vivo or in vitro,a se v e nt h e
most synchronized gametocyte induction protocols result in
partially asynchronous and mixed gametocyte stages [3,6]. This
problem is compounded in vivo,a sb l o o ds a m p l e dd u r i n g
infection is likely to contain both gametocyte and asexual
parasite populations, leading to a highly convolved transcrip-
tional mixture.
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microarray data, it is also of interest to develop a field-friendly
approach for detecting and quantifying both immature (indication
of conversion to sexual development) and mature (indication of
infectiousness to mosquito vector) gametocyte stages. Transcrip-
tional approaches such as RT-PCR, QT-NASBA and RT-LAMP
have been developed [7,8,9] using the established mature
gametocyte marker Pfs25 and the putative immature gametocyte
marker Pfs16. While these approaches enable sensitive detection of
these transcripts, it is unclear how the detection of these transcripts
- particularly Pfs16 - relates to actual gametocyte carriage [8]. The
development of a qRT-PCR-based assay has thus far been
impeded primarily because this approach cannot distinguish
transcript from genomic DNA when sequences are identical; the
majority of P. falciparum genes lack introns and thus have identical
sequences for both RNA and DNA. It is therefore worth
identifying novel intron-containing markers for which exon-exon
junction-spanning primers can be designed so that this approach
can be used for in vivo gametocyte quantification.
Our goal was thus to develop a new transcript-based
gametocyte model that addressed these challenges. Using a
deconvolution approach, we quantified the stage-specificity of
Plasmodium transcripts genome-wide and subsequently identified
intron-containing markers from across the full range of asexual
and sexual development. In order to identify expression patterns
specific to different gametocyte stages, particularly the immature
stages, existing in vitro asexual and sexual developmental time
course samples were re-analyzed to account for their mixed stage
composition. We further developed a qRT-PCR assay based on
these results and, applying the model in reverse, established an
algorithm to estimate the amounts of immature and mature sexual
and asexual stages in a patient sample based on the expression of a
small set of stage-specific markers. This was inspired by related
approaches that have been used successfully in dealing with mixed
cancerous/non-cancerous tissue samples [10,11] and with mixed
stages of budding yeast [12]. This framework is implemented for
public use at http://huttenhower.sph.harvard.edu/malaria2013;
as a transmission-focused tool, this system can be applied in
epidemiological settings, and as such will ideally support efforts
directed toward reducing malaria prevalence worldwide.
Results
A regression model characterizing genome-wide stage-
specific transcript expression in P. falciparum
Calculation of gene-specific expression contributions to
each life cycle stage. To identify expression patterns of
individual stage categories while accounting for mixed stage
composition, we began by using a labeled set of microarray data
with asexual and gametocyte proportions assessed manually by
microscopy [3,5]. For our purposes, we divided the P. falciparum
intra-erythrocytic developmenti n t oc a t e g o r i e st h a tr e f l e c t
physiologically relevant distinctions during the course of natural
infection in the human host. Specifically, we separated those
phases found sequestered in tissues from those found in
circulation, resulting in a total of five categories. These included
two asexual categories, i) the circulating ring stage (termed ‘‘R’’)
and ii) the sequestering trophozoite and schizont stage (termed
‘‘T’’). The three gametocyte categories were i) the young (Stage
I, termed ‘‘YG’’) and ii) intermediate (gametocyte stages II, III,
IV, termed ‘‘DG’’) immature gametocytes that are absent from
circulation and iii) the circulating mature stage V gametocyte
(termed ‘‘MG’’). For most analyses, we grouped YG and DG
together as one category encompassing all immature gameto-
cytes (termed ‘‘IG’’).
We subsequently constructed a constrained regression model to
identify the degree to which each P. falciparum gene’s expression
varied with respect to life cycle stage (Figure 1). The model
parameters encode the relative expression of each gene that can be
attributed to each life cycle stage, five of which are described
above and a sixth category representing transcriptional activity not
well-captured by any of these (Figure 1A). The model was initially
fit using microarray expression data from three time courses
spanning the P. falciparum intra-erythrocytic life cycle wherein the
stage distributions at each of the time points were determined by
microscopy [3,5] (Figure 1D-1).
In any one time point or sample, the total transcript abundance
yg for each gene g was modeled as a mixture of its abundance in
each specific stage. The mixture fraction xs represented the
fraction of parasites in stage s (Figure 1B), and the model was
constrained to require the sum of xs across stages to remain equal
to one. The contribution of each stage to g’s overall transcript
abundance was captured as bg,s parameters which provided not
only predictive accuracy but were also used to identify stage-
specific gene sets and pathways (Figure 1D-2). After identifying
each gene g’s stage-specific parameters bg,s, but before winnowing
them down to a minimal set of sentinel markers, we inspected the
resulting genome-wide characterization of P. falciparum life cycle
transcriptional activity in order to identify stage-specific pathways
and regulatory mechanisms.
Definition of stage-specific gene sets reveals parasite
biology. The model parameters bg,s provided a measure of the
amount of expression of each gene attributable to each stage s.T o
initially identify genes with stage-specific regulation, we selected
those genes for each stage where bg,s was at least two (for sexual
stages) or one (for asexual stages) standard deviations further above
mean than for any other stage. This process resulted in 637 stage-
specific genes distributed across five stages: 154 (R), 34 (T), 229
(YG), 34 (DG) and 186 (MG), with the top fifteen individual stage-
specific markers appearing in Figure 2A (see Supplementary Table
S1 for genome-wide analysis).
Author Summary
The human malaria parasite Plasmodium falciparum is
transmitted through a mosquito vector and causes over
half a million deaths per year. The microorganism cycles
through asexual and sexual life cycle stages, and its
successful transmission relies on cells in the sexual stage.
These stages are, however, present only at low levels
during infection; most infecting cells are asexually repro-
duced. It can be challenging to assign biomolecular
activity to particular parasite life cycle stages from typical
gene expression profiles, given the mixed stage compo-
sition of most samples. We developed a deconvolution
model to identify components of Plasmodium transcrip-
tional activity contributed by sexual and asexual life cycle
stages, initially using samples of known composition. From
these, we optimized a small set of stage-specific genes
with highly informative expression patterns and trained an
inference model to predict the stage composition of new
samples. The model successfully inferred the parasite’s
transition from asexual to sexual development over time
under laboratory conditions and identified a subset of
patient samples harboring transmissible sexual stages. The
system presented here can aid in epidemiological or
laboratory perturbation in which stage composition is an
important step in understanding and preventing malaria
transmission.
Inferring Stage Composition in Malaria Parasites
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stage-specific sentinel genes from these data, stage-specific
pathway activity was assessed genome-wide using Gene Set
Enrichment Analysis (GSEA). Since the standard gene sets
available for GSEA are somewhat sparse for P. falciparum,a
pathway database was constructed using the gene annotations in
PlasmoDB for the Gene Ontology [13] (see also Supplementary
Tables S2 and S3). These gene sets were then used with GSEA on
our model parameters, employing the genome-wide bg,s param-
eters z-scored across stages as a pre-ranked statistic for enrichment
testing. The resulting stage-specific pathway enrichments included
biological activities that are known to be associated with particular
stages in the asexual cycle, such as host cell remodeling in ring
stages (R) and host cell invasion and replication in the later stages
of the asexual cycle (T). Our analysis supports earlier observations
from the initial gametocyte transcriptome study and a more recent
early gametocyte proteome [3,14] that mitochondrial and lipid
metabolism are significantly up-regulated during early sexual
development, as well as factors involved in cell cycle control. We
also observed enrichment of endocytic pathways and cytoskeletal
remodeling during later stages of sexual development. These
processes are likely linked to hemoglobin uptake and exflagellation
during male gametogenesis, respectively (Figure 2B, and Supple-
mentary Table S2).
Signatures of natural selection. Interaction with the host
immune system can result in a higher rate of single nucleotide
polymorphisms (SNPs) in genes involved in these interactions.
Since life cycle stages vary in their level of interaction with the host
immune system, we were interested in whether any of our stage-
specific gene sets varied in signatures of natural selection. As a
Figure 1. In silico dissection approach developing a linear regression model to identify stage-specific gene expression profiles
within bulk parasite population gene expression. (A) Definition of physiologically relevant stage categories within P. falciparum development
for which we will identify stage-specific expression signatures. Stages are as follows: R: asexual ring, T: asexual trophozoite and schizont, YG: young
gametocyte ring and stage I, DG: developing gametocyte stages II, III, and IV, IG: all immature gametocytes (YG+DG), MG: mature gametocyte stage V,
and U: unexpected profile not captured by our defined stages. (B) Linear regression model for the deconvolution of bulk gene expression data from
mixed stage samples. Terms are as follows: yg: total expression of gene g, bg,s: expression of gene g attributed to stage s, Xs: proportion of the sample
that is stage s. (C) Marker Selection. Filters used to narrow down gene sets to our set of sentinel markers for field-applicable qRT-PCR assay. As we
chose markers for ring and trophozoite/schizont stages a priori based on published stage-specific gene expression data for asexual development
[4,5,46], we used this selection method to identify markers for the remaining gametocyte stage categories. (D) Overall stage prediction schematic.
doi:10.1371/journal.pcbi.1003392.g001
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determined the genetic diversity of individual genes within the
three gametocyte stages and two asexual stages (Figure 2C). For
this purpose, we calculated SNP p values for each gene based on a
sequence comparison from 25 culture-adapted strains from
Senegal [15]. SNP p quantifies the average number of pairwise
differences among a set of strains at a set of assayed SNPs. As a
complementary measure for positive selection between popula-
tions, we also calculated Fst [16] when comparing the 25 strains
from Senegal with a reference line from Honduras, HB3 [17]. Our
analysis demonstrated that none of the genes from within the set of
highly stage-specific asexual and sexual markers are under
increased selection compared to the genomic average, neither
within a population nor between two populations. This suggests
that the stage-specific transcripts identified by this process are
enriched, by these criteria, for gene products core to the regulatory
program or stage transitions themselves, excluding proteins that
would interact more directly with the host. Such conserved genes
are likely to serve as robust markers in lab and field samples alike.
Selection and validation of a sentinel marker set for stage
prediction
Marker selection overview. After characterizing the ge-
nome-wide stage-specific gene expression of P. falciparum,w e
proceeded to identify a small subset of markers sufficient to
recapitulate genome-wide resolution for stage prediction. To
combine predictive accuracy with biological interpretability, we
chose to identify the single markers representing each stage
category while still minimizing prediction error. This resulted in a
set of filtering criteria to obtain markers validated to be stage-
specific and suitable for use in microarray and qRT-PCR analyses
(Figure 1C and 1D-3).
Selection of asexual-specific and constitutively expressed
markers. To identify optimal markers for the better studied
asexual R and T stages, we began with the stage-specific gene sets
identified for each stage and first filtered based on presence of
intron(s). We also required mass spectrometry evidence confirming
the protein is expressed during asexual development [14,18]. Next,
we ranked genes based on frequency of retention during model
predictive marker selection (see Methods) and used raw expression
information such as lack of allelic expression variation, high
absolute expression levels [5], and stage-specific expression
evidence by expression timing [4] as additional filters. Based on
this process, we selected PFE0065w for the early asexual stage (R).
It encodes skeletal-binding protein 1 (SBP1), a well-characterized
component of parasite-induced membrane structures in the host
red blood cell (RBC) termed Maurer’s clefts [19]. Using these
same criteria, we selected PF10_0020 as the late asexual stage (T)
marker. The gene encodes a protein that is predicted to be
secreted into the host RBC [20] and contains a putative alpha/
beta hydrolase domain. It is highly specific for late asexual stages
not only based on the bg,s parameter, but also based on its
independent gene expression profile from a comparative tran-
scriptional analysis of three P. falciparum strains [4]. For the
baseline marker, we chose a constitutively expressed transcript as
determined by ranking all P. falciparum genes by the lowest
standard deviation across life cycle stages [3,5] and patient isolates
[21] and using a cut-off for high expression. The selected marker
PF11_0209 encodes a conserved protein of unknown function.
Selection of gametocyte stage-specific markers. To select
gametocyte markers, we began with the stage-specific gene sets
identified for each stage category as above (YG, DG, or MG) and
filtered first based on the presence of intron(s). Next, we retained
only those genes in which mass spectrometry data again confirmed
expression in the gametocyte development and absence in asexual
development, providing evidence both for stage-specific activity
and lack of evidence for non-specific stages. These criteria revealed
a shortlist of gametocyte-specific candidates with high predictive
accuracy, but in the case of the MG stage, no markers showed
high and stage-specific expression levels (as defined by the bg,s
parameter) comparable to the currently used gametocyte marker
Pfs25. We therefore decided to include Pfs25 as a MG marker to
model stage distribution in microarray data, as the major criterion
against using it for qRT-PCR (i.e. absence of an intron), does not
apply to the analysis of chip-based data. For the remaining
gametocyte stage categories in which highly expressed markers
were successfully identified, we ranked gene lists based on
frequency of retention during model predictive marker selection
and selected PF14_0748 and PF14_0367 to represent young (YG)
Figure 2. Stage-predictive gene sets are enriched for specific biological processes but show no signature of selection by diversity/
divergence measures. (A) Top 15 model bg,s parameters specific to each stage; values indicate for each gene the degree of its expression
attributed to each stage. (B) Gene set enrichments of GO and KEGG processes by stage (Supplementary Table S2). (C) Genetic diversity (within
patient) vs. divergence (between isolate) of the P. falciparum genome (see Methods for data sources), highlighting genes identified as stage-specific.
Several known markers are labeled for reference.
doi:10.1371/journal.pcbi.1003392.g002
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previously been identified as an early gametocyte marker [3,6],
and it has been demonstrated that its promoter can drive
gametocyte-specific reporter expression [6,22]. It encodes a
protein predicted to be exported into the host RBC with a
putative PHIST domain [20]. PF14_0367 has not been described
previously.
Initial validation of the model on microarray
samples. With a set of six sentinel markers identified, we
proceeded to test their ability to predict stage distributions in silico,
first using cross-validation over the available labeled microarray
data (Figure 1D-4). Having fit the complete regression model to
establish bg,s parameters, we subsequently retained only those six
markers’ values for prediction of a sample’s stage composition.
This was done by solving for Xs, the percent composition of each
stage, while employing a quadratic programming approach to
constrain the proportions of these stages to sum to 1. Making
predictions based on gene expression from our selected marker set,
we successfully predict the transition from asexual to sexual
development across the life cycle time course (Figure 3 A/B).
Prediction errors generated through cross-validation were mini-
mal, with total per stage, per sample, root mean squared error of
0.195 (Figure 3C).
Application of the model to in vivo malaria cohort and in
vitro drug perturbation microarray samples
To gauge how this modeling process performed on patient
microarray samples, we applied it to microarray data from two
patient cohorts, i) a previously published cohort of severe malaria
patients from Blantyre, Malawi collected in 2009 [23] and ii) a
cohort of uncomplicated malaria patients from Thies, Senegal
collected in 2008. While no staging information was available for
the Senegal patients, a subset of Malawi patients were previously
identified as gametocyte-positive by thick smears. The model
inferred that the majority of patients from both cohorts have a
strong ring-dominated profile, with the next largest subset being
late asexual stages (trophozoites and schizonts) (Figure 4A/B). For
the 10 Malawi samples in which gametocytes were observed by
thick smear, our model correctly identifies 4 (40%) as such, with 0
false positive developing or mature gametocytes predicted among
the 48 thick smear-negative patients (Figure 4A). Interestingly, two
thick smear-negative patients are predicted to have young
gametocytes, which are difficult to identify by thick smear
microscopy due to their morphological similarities with asexual
stages.
A subset of the uncomplicated malaria patients from Senegal
were also predicted to be gametocyte carriers (6 of mature, 1 of
developing and 1 of young gametocytes) (Figure 4B). As
microscopy-based information was unavailable for the Senegalese
cohort, we assessed how our gametocyte inferences correlated with
patient parameters. Of the 6 parameters we measured for this
cohort, illness duration and hematocrit differed significantly
between the group of patients inferred to be gametocyte carriers
and those inferred to be gametocyte-negative. The former had a
longer duration of illness (6.33 days61.02 SEM) than the latter
(3.84 days60.25 SEM, t-test p=0.0014) as well as a lower
hematocrit measured in percent cell volume (34.86%62.17 SEM)
than the latter (40.41%61.06 SEM, t-test p=0.031) (Supplemen-
tary Table S4). This finding agrees with published data on clinical
correlates of gametocyte carriage: long illness duration (greater
than 2 days) and anemia (hematocrit less than 30%) were both
independently found to be risk factors of gametocytemia in
uncomplicated malaria [24].
Evaluation of drug treatment on parasite stage
distribution in vitro. We concluded validation of the micro-
array model by using it to profile the effects of drug treatments on
parasite stage distribution. This application is of particular interest
as it was recently demonstrated that currently used anti-malarial
treatments including artemesinin combination therapy (ACT)
have limited efficacy against mature gametocytes [25]. As a proof-
of-concept we performed in vitro time course experiments for
subsequent microarray analysis with a gametocyte-producing line
of P. falciparum (3D7) in which parasites were grown in the presence
of two experimental antimalarial compounds, Genz-666136 and
Genz-644442. Genz-666136 is known to inhibit parasite dihy-
Figure 3. Marker selection yields a set of sentinel markers with high predictive accuracy. (A) Actual and (B) inferred stage distributions
across five microarray time courses (two asexual and three sexual) with reference stage distributions determined by microscopy. Six markers were
used to make these predictions, five as identified through filtering criteria (Table 1) and the previously established mature gametocyte marker Pfs25.
(C). Bootstrap cross-validation of error rates expected per stage in model inferences. Violin plots show expected density, with internal boxplots
detailing the 25
th–75
th percentiles and 1.56fences.
doi:10.1371/journal.pcbi.1003392.g003
Inferring Stage Composition in Malaria Parasites
PLOS Computational Biology | www.ploscompbiol.org 5 December 2013 | Volume 9 | Issue 12 | e1003392droorotate dehydrogenase (DHODH) enzyme, which catalyzes the
rate-limiting step in de novo pyrimidine biosynthesis [26]. Genz-
644442 was identified as a potent antimalarial compound with
unknown target in a recent small molecule screen [27]. Plasmodium
sexual differentiation in response to these compounds has not been
previously explored.
In both the treated and untreated control samples, our model
predicted an initial, subsequently decreasing fraction of the
population to consist of young gametocytes (Figure 4C). The
presence of young gametocytes is likely due to increased
conversion of gametocytes in response to growth at the relatively
high starting parasitemia used, an established induction factor of in
Figure 4. Application of microarray model to malaria patient cohorts and drug perturbation time courses. (A) Model inferences for 58
pediatric severe malaria patients from Blantyre, Malawi. Stars indicate subjects in which at least one gametocyte was observed by thick smear
examination, a particularly sensitive assay (14 patients). (B) Model inferences for 39 adult uncomplicated patient samples from Dakar, Senegal. (C)
Model inferences for in vitro time course experiments in which samples were taken at 10, 20, 30, and 40 hours post-invasion. Time courses were
performed in the presence of one of two antimalarial compounds, Genz-666136 and Genz-644442, or under normal growth conditions (control).
doi:10.1371/journal.pcbi.1003392.g004
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in both drug-treated time course experiments 20 hours post
invasion, while in the control experiment, we observed an
expected progression from ring to trophozoite stages. The
presence of mature gametocytes at 20 hours could reflect a
differential killing effect of the drug on asexual stages versus
mature gametocytes; this would induce exactly the inferred
increase in relative proportion of gametocytes. A drug-induced
stalling of asexual development is predicted in both time courses,
as evidenced by the decreasing fraction of late asexual stages from
10 to 20 hours under drug treatment, compared with a constantly
increasing late asexual fraction in controls (Figure 4C).
Treatment with both compounds, but to a greater extent with
Genz-666136, resulted in an increasing proportion of transcrip-
tional signature that could not be assigned to one of our stage
categories (shown as ‘‘unknown’’, gray in Figure 4C). It is possible
that the increase in unknown transcriptional signature corresponds
to an increase in dying parasites across the drug-treated growth
experiment. By microscopy, stalled and dying asexual parasites
could be observed in both drug-treated time courses.
Application of the model for qRT-PCR–based inference of
stage composition in vitro and in malaria patients
We next sought to test a variation of the microarray-based
model for application to transcriptional measurements obtained by
PCR, which might eventually be more appropriate for a field
assay. As no MG marker that achieved our filtering criteria (see
Figure 1C) for qRT-PCR also matched both the high expression
levels and stage-specificity of the existing Pfs25 marker for
gametocyte detection, we assessed the utility of the YG and DG
markers in combination for the prediction of immature and
mature gametocyte quantities when applying the model to qRT-
PCR data. Specifically, PF14_0748 and PF14_0367 were likely to
represent immature (IG) and mature (MG) gametocytes in
combination, as PF14_0367 had a bg,s parameter similar to that
of Pfs25 in mature gametocyte stages. We therefore cross-validated
this 5-marker PCR set (Table 1) comparably to the 6-marker
microarray set, using the in vitro microarray time courses as
described above. The simplified model remained able to predict
stage distribution accurately, with a root mean squared error
comparable to that of the 6-marker model (Supplementary Figure
S1).
In order to create a qRT-PCR assay for our sentinel transcripts,
we designed exon-exon junction spanning primers (distinguishing
transcripts from genomic DNA) and sequence-specific probes
(distinguishing transcripts from non-specific background amplifi-
cation). Following confirmation that our primer/probe sets
selectively amplified cDNA and not genomic DNA or non-specific
products, we validated the stage-specific expression using in vitro-
derived asexual and sexual stage RNA (Table 1, and supplemen-
tary Figure S2A, and Table S5 for optimization and validation of
qRT-PCR parameters). For these experiments, we used the
gametocyte-producing reference line 3D7 and a gametocyte-
deficient clone thereof (termed F12 [29]) to confirm the stage-
specificity of each of our sentinel markers. Normalized expression
data from time courses of 3D7 and F12 confirmed stage-specificity
of our sentinel marker set (Supplementary Figure S2B). The
asexual markers alternate with respect to time points in which
there were predominately rings or trophozoites and schizonts in
the culture, with similar results for both the F12 and 3D7 lines.
The sexual markers demonstrate stage-specificity within the 3D7
time course and no appreciable expression in the F12 line once
normalized. Specifically, PF14_0748 expression is detected in the
early and mid gametocyte time points, while PF14_0367
expression is detected in both mid and late time points.
In vitro stage prediction using qRT-PCR. Having vali-
dated the stage-specificity of each marker in vitro and tested their
predictive-ability as a set in silico, we next compiled a larger set of in
vitro samples with known distributions of parasite life cycle stages in
order to tune a set of model parameters for stage prediction
specifically using qRT-PCR-based expression measurements. For
this purpose, we used the data from our in vitro validation on the
3D7 and F12 lines, in combination with additional in vitro samples
generated from across a 48-hour period of asexual development,
and a two-week period of gametocyte conversion. For the
additional data points, we used a transgenic line in 3D7
background, termed 164/GFP, that expresses fluorescent protein
under the gametocyte-specific PF10_0164 promoter [22]. This
parasite line enabled us to determine stage composition with high
accuracy by both Giemsa stain and fluorescence microscopy
throughout gametocyte development and starting at the earliest
stages (Figure 5 A/B). The model was trained on these qRT-PCR
datasets as described earlier for microarray data, again determin-
ing the contribution bg,s of each stage to our five markers’
expression and performing cross-validation to evaluate the final
prediction error rates per stage. Again, we see that the model
accurately predicts the absence of sexual stages in F12 and low
parasitemia cultures of 3D7 while predicting young gametocytes in
Table 1. Genes used in qRT-PCR assay.
Name Accession Stage-Specificity PCR Efficiency Limit of Detection
Skeleton-binding protein 1
(SBP1)
PFE0065w ring 90.43% 10
1 pg cDNA (appx 30 rings)
Alpha-beta hydrolase,
putative
PF10_0020 trophozoite/schizont 87.82% 10
3 pg cDNA (appx 1000 troph/
schizonts)
Plasmodium exported
protein (PHISTa)
PF14_0748 early - mid gametocyte 92.17% 10
2 pg cDNA (appx 30 immature
gametocytes)
Conserved Plasmodium
protein
PF14_0367 mid - late gametocyte 89.77% 10
3 pg cDNA (appx 20 mature
gametocytes)
Conserved Plasmodium
protein
PF11_0209 all stages 92.06% 10
2 pg cDNA (appx 500 total
parasites)
Details of the qRT-PCR compatible marker set selected by our combined filtering process. PCR efficiency was calculated based on the slope of the line after running a
series of 10-fold dilutions of mixed-stage cDNA (Figure S2A). Limit of detection was calculated based on the number of parasite stages estimated to be present in the
last dilution where the marker was detected. Detection limit ranged from 10
1–10
3 pg cDNA, corresponding to approximately 20–200 cells, depending on the stage.
doi:10.1371/journal.pcbi.1003392.t001
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PLOS Computational Biology | www.ploscompbiol.org 7 December 2013 | Volume 9 | Issue 12 | e1003392Figure 5. qRT-PCR assay optimization. (A) We collected and analyzed a range of in vitro time points with varying contributions of asexual and
sexual stages, from both gametocyte-producing and non-producing lines of 3D7. Absolute number of parasites stages that went into each qRT-PCR
reaction well is plotted. (B) Relative qRT-PCR-based gene expression of stage-specific markers for R, T, IG and MG are shown for time points
corresponding vertically to those in part A. (C) Inferred proportion of each stage in the total parasite load (model predictions) are shown
corresponding vertically to the time points in A and B, plotted as a percentage of total parasites in that sample. (D) In vivo peripheral blood samples
from severe malaria patients in Blantyre, Malawi were collected and analyzed. Absolute numbers of parasites stages per mL of blood, as determined
by microscopy, are plotted. (E) Relative qRT-PCR-based gene expression of stage-specific markers for T, IG and MG (normalized to SBP1) is shown for
time points corresponding vertically to those in part D. (F) Inferred proportion of each stage (model predictions) are shown corresponding vertically
to the time points in D and E. Stars indicate subjects in which gametocytes were observed by highly sensitive thick smear examination (one or more
gametocytes in 100 high power fields).
doi:10.1371/journal.pcbi.1003392.g005
Table 2. Admission characteristics of severe malaria patients tested by qRT-PCR, Blantyre, Malawi, 2011.
Demographics
Mean age (months) 52.9
Age range (months) 5–156
Gender 47.3% female
Parasitemia
Geometric mean parasite density/ml [95% CI] 48349 [29051–80466]
Median parasite density/ml 74800
Parasite density range/ml 69–945500
Gametocytemia
Gametocyte prevalence (Screen of 100 HPF on thick smear) 11.9% (8/67)
Gametocyte density range/ml (Counts per 500 WBC on thick smear) 0–370
Blood was sampled from participants who met the clinical case description of cerebral malaria during the malaria transmission season in 2011. All patients were from
Blantyre, Malawi and surrounding areas. Parasitemia was measured by microscopy and qRT-PCR was performed on an RNA sample stored in trizol.
doi:10.1371/journal.pcbi.1003392.t002
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distribution seen in the early time points of the drug profiling
experiments (see Figure 4C). Developing and mature gametocytes
are observed in the later mixed gametocyte induction cultures
(Figure 5C).
Application of the qRT-PCR and model predictions to a
cohort of severe malaria cases. To finally test the sensitivity
of our system in an epidemiological context, peripheral blood
samples from a cohort of severe malaria patients in Blantyre,
Malawi were collected over the course of the malaria transmission
season in 2011 (see Table 2 for patient cohort characteristics).
Smears were quantified using standard methods of ring quanti-
fication (thin smear microscopy and grid) and detailed gametocyte
quantification (highly sensitive thick smear microscopy screen of
100 high power fields for positivity, then quantification against 500
white blood cells, see Figure 5D).
Of the 86 samples examined, 8 were gametocyte-positive by
thick smear. We performed qRT-PCR on these samples and 8
matched gametocyte-negative samples with equivalent parasit-
emias. Seven of the 8 (88%) microscopy-positive gametocyte
carriers were qRT-PCR positive for one or both gametocyte
markers, while only three of the 8 (38%) matched microscopy-
negative individuals were positive for either gametocyte marker,
with highest levels of expression observed in the microscopy-
positive gametocyte carriers (Figures 5E). This provides an
approximate baseline of error rates for existing single-marker
qRT-PCR approaches.
In comparison, our model provided additional detail, first
predicting that most patients have a ring-dominated profile as
expected in peripheral blood (Figure 5F). A number of individuals
were predicted to have trophozoites and schizonts, which has been
shown to be associated with severe malaria [30]. The model
predicted gametocyte fractions in four patients, all of which were
gametocyte-positive by thick smear. We thus achieve a compara-
ble false negative rate (50%) and a higher true positive rate (100%)
to single-marker qPCR as compared to standard thick-smear
microscopy.
Discussion
Several highly sensitive single-marker molecular assays are
currently used to detect Plasmodium gametocytes. None of these
existing tools have been appropriate for detection and quantifica-
tion of the relevant range of parasite stages present during
infection, however, due primarily to the lack of a sufficiently broad
panel of stage-specific markers. Further, since malaria parasite
populations exist as mixtures of the different phases of the life
cycle, assays combining multiple markers require customized
computational analysis methods for dealing with this complexity.
We combined the development of such a bioinformatic deconvo-
lution approach with panels of stage-specific, intron-containing
markers appropriate both for microarray analysis and a newly
developed qRT-PCR assay. This multi-marker platform enabled
us not only to detect gametocyte carriers but primarily to infer the
relative amounts of sexual and asexual stages within a sample. We
provide an implementation of this platform for further develop-
ment and application, particularly for refinement in field settings.
This process can also be adapted bioinformatically by the
exclusion or inclusion of markers to answer specific questions,
such as determination of parasite sex ratios that are known to
influence mosquito infectiousness [31].
Our deconvolution model provided the opportunity to define
stage-specific gene sets and to characterize the biology of these
stages’ expression programs using tools such as GSEA, even in the
absence of transcriptional data from pure stage populations. For
example, our GSEA analysis confirms earlier studies that
suggested increased mitochondrial and lipid metabolism during
gametocyte development [3,32]. Interestingly, the analysis also
suggests significant enrichment of several markers related to
endocytic trafficking in late gametocyte development but not in
any other parasite stage. The biological significance of this
observation remains to be determined. To put such findings into
context and ultimately describe the gametocyte transcriptome at
high resolution, a systematic transcriptional re-analysis of the
entire P. falciparum gametocyte cycle using isolated and synchro-
nous gametocyte stages will be required.
Transcriptional approaches have significantly increased the
sensitivity of gametocyte detection in field-compatible assays
[8,9,33,34,35]. However, these have been limited to either (i)
qualitative assessments of multiple gametocyte markers, i.e. RT-
PCR of immature and mature gametocyte markers [35], or (ii)
quantitative assessments of mature gametocytes only, i.e. QT-
NASBA of the gamete surface antigen Pfs25 [8]. In order to
properly define the reservoir of parasite and gametocyte carriers in
the field, it is imperative to determine both the absolute parasite
burden and the stage composition of parasites in the blood
circulation. Challenges have prevented the development of a
diagnostic that can measure the latter, such as (i) the lack of
transcriptional analysis methods to identify gametocytes with high
specificity in a sample containing a mixture of stages, (ii) the lack of
validated immature gametocyte markers, and (iii) the lack of
known intron-containing qRT-PCR compatible markers for all
stages. We tackled these challenges by developing a model specific
to the quantification process and ensuring that it was compatible
with both microarray and qRT-PCR measurements. This is
distinct, of course, from models that would focus only on sensitivity
and specificity of gametocyte detection from such data, which
represent a potentially fruitful course of future computational
investigation. Instead, by incorporating relative expression values
of the markers, the model allowed us both to identify a subset of
patients as gametocyte carriers and to additionally quantify sub-
categories of immature and mature gametocyte fractions within
the mixture of stages in the bloodstream.
Following validation of our model on samples for which stage
composition was known, we applied our model to two microarray
data sets in which stage composition was unknown: (i) a cohort of
uncomplicated malaria patients, and (ii) two in vitro growth
experiments in the presence of drug. In the former, we found
that both mean illness duration and hematocrit differed between
inferred gametocyte carriers and non-carriers, in agreement with
published data demonstrating that long illness duration and low
hematocrit is linked to gametocyte carriage [24]. In the latter, we
observed an increase in the fraction of mature gametocytes as well
as unexplained transcriptional signature upon the addition of drug
treatment to parasites. The enrichment of mature rather than
young gametocytes in response to drug treatment suggests that the
drug selectively kills asexual stages, leaving gametocytes unaffected
rather than inducing the development of new young gametocytes.
The increase in unexplained signatures likely indicates the
transition to unhealthy, dying parasite fractions. These applica-
tions demonstrate the range of potential uses for this inference
tool.
As the exon-exon junction spanning primer/probe sets for 5
markers designed here represent the first attempt at a multi-
marker gametocyte-staged qRT-PCR assay, further modeling of
PCR-specific measurement error and careful standardization of
experimental protocol for this difficult task will both improve field
inferences. Like the microarray expression model, however, this
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sexual development across multiple in vitro experiments even on
first application. When used initially in vivo for blood samples from
a cohort of children with severe malaria in Malawi, the system
successfully identified a subset of patients as immature and/or
mature gametocyte carriers. Because immature gametocytes in
particular are present in the body several days before the more
mature forms emerge, our approach for detecting them could be
used in further investigations into factors that influence gameto-
cyte conversion in vivo.
The assay and algorithm framework presented here has
potential for use in epidemiological studies such as those of
asymptomatic carriers, who likely represent a major reservoir for
malaria transmission. Multiple such studies are already ongoing
and will yield additional samples to further optimize computa-
tional models of gametocyte differentiation. This is also true of
data generated from other sensitive expression platforms such as
glass-slide arrays or Nanostring. The inference process may thus
have applications in better understanding the natural progression
of malaria in the human host, by identifying gametocytes earlier in
the course of infection and determining the impact of specific drug
treatments on gametocyte development. By scaling to future
population-level screens, the resulting information will help better
characterize the epidemiology of gametocytemia based on malaria
transmission intensity, geography, climate and season.
Materials and Methods
Ethics statement
The institutional review boards of the Harvard School of Public
Health, Brigham and Women’s Hospital, the University of Malawi
College of Medicine, and the Ministry of Health in Senegal
approved all or parts of this study. Consent was obtained from the
patient or a child’s guardian.
Patients and sample collection
Malawi patient isolates. Patients who enrolled in an
ongoing severe malaria study [36] at the Queen Elizabeth Central
Hospital during the 2009 and 2011 transmission season were
included in this study. These patients were between the ages of 1
month to 14 years of age and came from Blantyre, Malawi and
surrounding areas, where transmission is high and seasonal. All
patients enrolled in the study met the clinical criteria for severe
malaria, and severity was classified by Blantyre Coma Score [37].
The majority of patients were treated with an antimalarial drug
(majority received quinine) within the 24 hours prior to admission.
Parent or guardians of all children enrolled in the study were
consented in writing in their own language by local native-
speaking healthcare staff (nurse or doctor). The samples from the
2009 cohort have been described in detail in a recent publication
[23]. For the 2011 cohort, a venous blood sample was drawn at
admission and a 500 ml sample of whole blood was added directly
to Tri-Reagent BD (Molecular Research Center), mixed vigor-
ously and stored at 280 C until processing. Simultaneously, thick
and thin smears were collected and stored for later processing.
Patients were classified as ‘‘gametocyte-positive’’ if they had 1 or
more gametocytes in 100 thick smear high power fields (HPF). For
standard gametocyte quantification by thick smear, we quantified
gametocytes per 500 white blood cells (WBC).
Senegal patient isolates. Patients who enrolled in a study of
uncomplicated malaria in Thies, a low malaria endemicity suburb
of Dakar, Senegal in October 2008 during transmission season
were included in this study. Patients who presented to Section de
Lutte Antiparasitaire de Thies, with signs and symptoms of
malaria were offered enrollment if they had microscopic confir-
mation of malaria infection and had mild symptoms. At the time of
admission, a blood sample was taken from which 4.5 mL was
transferred into Tri-Reagent BD (Molecular Research Center),
shaken vigorously for 15 seconds, and frozen at 280uC for
transcriptional analyses. General demographic data, history of
illness and hematocrit were recorded. Samples were transported to
HSPH in a liquid nitrogen dry shipper, thawed in a room
temperature water bath and RNA isolated according to manu-
facturer’s instructions (Molecular Research Center). Simultaneous-
ly, thin smears were collected and stored for later processing.
P. falciparum asexual and sexual in vitro culture
A transgenic line, 164/GFP, of a gametocyte-producing clone of
the 3D7 strain of P. falciparum was used to produce the mixed stage
samples for model training and validation. This transgenic line,
which aided in the quantification of gametocyte stages, produces
stage-specific GFP expression under the PF10_0164 gene
promoter, as described previously [22]. A previously characterized
non gametocyte-producing clone, F12, of the 3D7 strain was used
to confirm stage-specificity of gametocyte markers [29]. Culture
conditions were as described previously [38], maintaining the
parasite line in O+ blood at 4% hematocrit in RPMI-1640 media
supplemented with 10% human serum. Cultures were kept at
37uC in a chamber containing mixed gas (5% CO2,5 %O 2, 90%
N2). Prior to induction, asexual parasite cultures were synchro-
nized for two cycles with 5% D-sorbitol [39], and subsequently
induction of gametocytogenesis was performed according to the
Fivelman protocol [28]. Briefly, asexual parasites were grown to a
high parasitemia in the presence of partially spent (‘‘conditioned’’)
medium, and then sub-cultured at the schizont stage into new
dishes containing fresh media and erythrocytes. One of two
methods was used to reduce the amount of asexual stages in the
cultures: Treatment with D-sorbitol was applied on two days later
to lyse asexual trophozoite/schizont stages and selectively enrich
for unaffected early gametocytes, or N-Acetyl glucosamine was
added to the medium one day later and every subsequent day to
selectively kill asexual stages.
P. falciparum drug perturbations
A 3D7 line was used to study the effect of drug perturbations on
parasite growth. Culture conditions were performed as described
above. Asexual parasite cultures were synchronized for three
cycles with 5% D-sorbitol, and expanded to a parasitemia of 5–
6%. Hematocrit was increased from 3 to 6% at the late schizont
stage using fresh blood. Upon reinvasion drugs were added to the
culture at a concentration of 56IC50. Drug-treated and control
parasites were harvested at 10, 20, 30, and 40 hours post-invasion
and RNA was extracted (Qiagen).
Standard and fluorescence microscopy
In order to accurately quantify the stage distribution of parasites
in our in vitro samples, we used a combination of standard and
fluorescence microscopy. Parasite stage distribution was monitored
throughout the parasite synchronization and induction protocol
using Wright’s Giemsa stain applied to thin blood smears.
Quantification of asexual rings and trophozoite stages, as well as
developing and mature sexual stages was done directly by light
microscopy. In order to quantify early stages of sexual develop-
ment that are morphologically similar to asexual stages, we used a
combination of live imaging and immunofluorescence microscopy.
Live imaging was performed using the transgenic 164/GFP line.
Parasites were analyzed using the FITC channel on an inverted
epifluorescence microscope (Zeiss) and quantification was done of
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Hoechst (+) parasites. Immunofluorescence assays were performed
with cell monolayers on glass slides, prepared as described
previously [40]. For labeling with the constitutive gametocyte
marker Pfs16, slides were fixed in ice-cold methanol, blocked with
5% nonfat dry milk powder, incubated with polyclonal mouse
antibody against Pfs16 (1:2500) [41], washed and incubated with a
secondary antibody conjugated to Alexa 488. Parasite nuclei were
labeled with DAPI and quantification was done on the proportion
of FITC(+) parasites out of the total number of DAPI(+) parasites.
For time points in which we had data from both live and
immunofluorescence experiments [41], the quantification of early
gametocytes from both methods was averaged to give the final
amount.
Quantitative reverse-transcriptase PCR assay
Primer & probe design. We have developed a quantitative
reverse-transcriptase PCR (qRT-PCR) assay for the quantification
of five key gene transcripts. The assay includes primers and probes
designed against the markers described in the Results section.
Primers and probes were designed by hand using the PrimerEx-
press software (Applied Biosystems) and following recommended
guidelines for qRT-PCR primer and probe design. Primers were
specifically designed to cross exon-exon junctions, so as to reduce
genomic DNA amplification. In addition both primers and probes
were checked for homology against Plasmodium or human
homologous sequences using PlasmoDB and NCBI Blast in order
to eliminate the chances of non-specific amplification (see also
Supplementary Table S5 for primer and probe validation).
RNA extraction, DNAse digest and reverse
transcription. RNA from mixed stage cultures was preserved
and extracted and processed as previously described [42]. Briefly,
samples were stored in TriReagent (Molecular Research Center)
until use. For sample processing, RNA was extracted by the
phenol-chloroform method followed by DNAse digest (Ambion),
and a second phenol-chloroform extraction for protein removal
and sample concentration. For first strand synthesis we used the
SuperScript III First Strand Synthesis kit (Invitrogen).
qRT-PCR assay optimization. Amplification of the correct
target sequence was confirmed by gel electrophoresis and melt
curve analysis using SYBR Green (BioRad). The ability of primer
pairs to discriminately amplify the cDNA product was determined
by performing qRT-PCR on mixed stage P. falciparum cDNA and
genomic DNA (same extraction, minus DNAse digest and reverse
transcription for genomic DNA). The possibility of non-specific
amplification with host template was ruled out by performing
qRT-PCR on cDNA and genomic DNA from a human whole
blood sample from which GAPDH was successfully amplified (data
not shown). Primer pair efficiencies were determined by calculat-
ing the slope of the crossing threshold (CT) values on 10-fold serial
dilutions of mixed stage cDNA (Supplementary Table S6).
Sensitivity assessment. Sensitivity of this assay was deter-
mined using 10-fold serial dilutions of mixed stage cDNA.
Sensitivity was estimated by calculating the amount of parasites
of each stage that were present in the sample at the limit of
detection by qRT-PCR.
Microarray expression analysis
RNA (from peripheral blood of Senegalese patients and
cultured in vitro drug perturbations) was assessed by Bioanalyzer
(Agilent), and high quality RNA samples were labeled and
hybridized to an oligonucleotide array (Affymetrix) custom-
designed for the P. falciparum 3D7 genome, PlasmoFB, as published
previously [5]. The raw CEL files were condensed into GCT
expression files using RMA and the default parameter settings in
ExpressionFileCreator in GenePattern [43].
Development and validation of the constrained linear
regression model
Development. A constrained linear regression model was
constructed to estimate the contribution of each stage to the
overall transcript abundance from training data
The total transcript abundance yg for each gene g was modeled
as a mixture of its abundance in each specific stage U,R,T,IG or
YG+DG and MG. The mixture fraction xs represents the
proportion of parasites in each stage s and is thus constrained
between zero and one.
Microarray model training to establish genome-wide
stage-specific expression. This model was first fit to estimate
the contribution of each stage to each transcript’s abundance,
parameters bg,s. Labeled training data were obtained from a
published in vitro time course [3,5] in which the stage-specific
parasite fractions xs were known from fluorescence microscopy.
The model was fit to these training data using lm, the linear model
method without an intercept, in R, resulting in a table of 5,159
genes across the 5 erythrocyte stage-specific parameters (Supple-
mentary Table S1).
Gene set enrichment analysis. GSEA was performed using
the pre-ranked bg,s parameters determined in this manner in
combination with a newly derived set of P. falciparum-specific gene
sets. For this purpose P. falciparum Gene Ontology [13] leaf
annotations were obtained from PlasmoDB and propagated into
the ontology using the Sleipnir functional genomics library [44].
Gene sets containing ,2 genes were removed, and overlapping
gene sets were merged (combining the top 10% of gene set pairs
ranked by the fraction of shared genes relative to the total size of
the smaller set). These gene sets were finally combined with the P.
falciparum pathways from KEGG [45]. Enrichment of the resulting
pathway sets (Supplementary Table S3) was then assessed in the
five pre-ranked parameter lists using GSEA over 1000 bootstraps.
Model application to predict stage distribution
Given the learned model parameters bg,s from stage-labeled data
with known xs, the model was inverted to infer the unknown stage
distributions xs in new samples. A quadratic programming
approach was used to solve the system of linear equations with
the constraint that the proportions of all stages must sum to 1 and
that each stage contributes a non-negative fraction of expression:
y~b
Tx
subject to S
s[fU,R,T,IG,MGg
xs~1
and x§0
We implemented this process in the R function quadprog and
solved for the stage distributions using the sets of six (for
microarrays) or five (for PCR data) markers ultimately selected
as follows.
Co-normalization of reference and inference data
sets. Microarray data sets. For model inference in microarray
data, missing values remaining in input microarrays were imputed
per dataset using the row mean across all samples. For each set of
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batches, values used in the modeling process were co-normalized
using quantile normalization. Datasets were first merged, retaining
only gene names common among both datasets and the resulting
merged data was jointly quantile normalized.
qRT-PCR data sets. Similarly for qRT-PCR expression values,
raw values were delogged using the formula to bring the data into
a range of log-scaled abundance counts comparable to microarray
samples. Missing values were imputed to the lowest detectable
limit on our qRT-PCR assay, which corresponds to a CT value of
50 or 3.23 in delogged expression space. Again considering sets of
reference and inference data together, data were median
normalized, such that all samples had the same median value
(i.e. adjusting expression values by subtracting the column median
and adding the global median).
Stepwise backward marker selection. To identify reduced
marker sets appropriate for inference, we used the model’s
inference process to perform in silico marker selection based on
greatest accuracy of stage inference in our labeled microarray
training data. Iteratively, model inference was performed on the
total labeled microarray time courses using the complete
transcriptome. Each individual gene was removed, the model re-
applied, and the marker inducing the smallest increase in inference
error removed. These steps were repeated to a minimum of five
markers, and the entire process repeated 15000 times. The
resulting whole transcriptome rankings were averaged to assign a
rank-average selection preference to retention of each Plasmodium
gene as one criterion for our reduced marker set.
Bootstrap cross validation. The model’s accuracy in each
labeled microarray and qPCR training set was evaluated by 10-
fold bootstrap cross validation. For each fold, one third of
conditions were selected for holdout with replacement to form a
test set. The model was fit as above to the remaining training data
and its accuracy in predicting new expression samples was
calculated using a per stage root mean square error in the test set.
Supporting Information
Figure S1 Performance of the 5 marker model on
published microarray data sets. (A). Actual and (B) inferred
stage distributions across five microarray time courses (two asexual
and three sexual) with reference stage distributions determined by
microscopy. Five markers were used to make these predictions
(Table 1). (C). Bootstrap cross-validation of error rates expected per-
stage in model inferences. Violin plots show expected density, with
internal boxplots detailing the 25
th–75
th percentiles and 1.56fences.
(TIF)
Figure S2 qRT-PCR assay optimization. (A) Efficiency of
qRT-PCR reactions using 10-fold dilutions of mixed parasite
cDNA. 4 to 6 dilutions were assessed for each primer, and
efficiencies were in the acceptable range for all 5 primers (87–92%).
R
2-values were all greater than 0.96. Technical variation between
replicates was very low: the average standard deviation between
technical replicates was 0.243 and ranged between 0.01 and 1.543.
(B)Stage-specificityofqRT-PCRmarkers.Usingtwoclonesof3D7,
F12 (gametocyte deficient) and wild type (gametocyte producer), we
performed in vitro gametocyte inductions and collected parasite
samples for microscopy and qRT-PCR at days 21, 0, 1, 5, 10
according to the Fivelman et al protocol [28]. Results, displayed as
relative expression normalized to constitutively expressed marker
PF11_0209, confirm stage-specificity of markers.
(TIF)
Table S1 Annotated gene list and metadata. Annotations
of the 5160 genes in the P. falciparum transcriptome used in the
analysis, including the frequency of selection in our subsampling
and backward selection steps, presence of an intron, contribution
of expression to stage, determination of stage specificity, product
description and population genetic parameters of total SNP
counts, diversity and divergence.
(XLSX)
Table S2 Complete GSEA results per stage. Results for
each stage in our microarray model, wherein the per gene z-scored
contributions of expression to that stage were ranked and were
characterized for enrichment in functional pathways.
(XLSX)
Table S3 GSEA gene sets. Gold Standard Catalog of GO and
Kegg pathways obtained from individual GO slims from
PlasmoDB and the GO ontology integrated into the GO
hierarchical structure.
(XLSX)
Table S4 Clinical parameter data for Senegal cohort.
GraphPad Prism Version 6.0 was used to compare two groups
(those inferred to have gametocytes and those not inferred to have
gametocytes) for six continuous variables measured at admission:
age, hematocrit, temperature, illness duration, height, and weight.
A multiple t-test analysis was performed, analyzing each variable
individually, and then using false discovery rate (Q=0.25) to
determine significance.
(DOCX)
Table S5 Additional qRT-PCR assay optimization data.
Primers were specifically designed to cross exon-exon junctions, so
as to reduce genomic DNA amplification, and were checked for
homology against Plasmodium or human homologous sequences
using PlasmoDB and NCBI Blast in order to eliminate the chances
of non-specific amplification. Using our primer set with sequence-
specific probes showed no cross-reactivity with genomic DNA or
human templates. Our primer sets also greatly reduced the
amount of genomic DNA amplification even using SYBR (CT.39
as compared with DNA-amplifying control marker at CT=25),
yet it was not zero.
(DOCX)
Table S6 Primer and probe sequences used in qRT-
PCR. Sequences for the reverse and forward primers and minor
groove-binding fluorescent probes used in the qRT-PCR assay.
(DOCX)
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